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Abstract
Purpose
The study purpose was to investigate the acceptability and utility of, and preference for,
wearable activity trackers (WATs) amongst cancer survivors living in regional and remote
areas of Western Australia.
Methods
Twenty participants were recruited (Mean age = 63 years, SD = 13) to test two to three track-
ers from five available models (Fitbit Alta, Garmin Vivofit 2, Garmin Vivosmart, Polar loop 2
and Polar A300). Participants wore each device for two weeks, followed by a one-week
washout period between devices. Interviews were conducted with participants to explore
user perceptions and experiences. Interview transcripts were analysed using thematic
analysis.
Results
Four main themes emerged: (i) Consciousness raising; (ii) Prompts and Feedback; (iii)
Accuracy and registry of activities; and, (iv) WAT preferences and features.
Conclusions
WATs were acceptable and useful to cancer survivors. WATs increased self-awareness of
physical activity, provided real time feedback in relation to step goals, and reinforced prog-
ress and efforts towards goals. The aesthetics of the WATs were deemed crucial in deter-
mining preference and likelihood of use.
Implications for cancer survivors
Future interventions may do well to have two different WATs available for participants to
choose from, according to activity preferences, aesthetic preferences, and display size.
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Introduction
Cancer is a leading cause of disease burden worldwide [1]. Effective physical activity (PA)
interventions to curb the growth in inactivity and prevent chronic illness in cancer survivors
are essential [2–3]. PA prevents cardiovascular disease (CVD) [4–5] and can reduce the risk of
cancer recurrence [6–9] and improve overall survival, yet few survivors meet current PA
guidelines of at least 150-minutes per week of moderate-intensity exercise [10]. Furthermore,
there are significant geographic inequalities in cancer survival, which need to be addressed
[11]. Effective, distance-based PA interventions are essential in order to reduce such geo-
graphic inequalities in survival.
Evidence from trials support the efficacy of PA interventions in producing short-term, but
not long-term change in cancer survivors [12,13]. Most interventions tend be supervised and/
or facility-based, and subsequently resource-intensive. Home-based and distance-based inter-
ventions (such as those using wearable activity technology) may mitigate access and transport
issues, and are less expensive than supervised, facility-based programs requiring participants
to attend classes or maintain a health club membership [14]. There is a current gap in the liter-
ature on less intensive home-based interventions that could be cost-effective, and more
scalable.
Interventions that offer opportunities for self-monitoring have successfully increased PA in
cancer survivors [13], and survivors report that self-monitoring is a helpful tool for improving
PA [15,16]. Wearable activity trackers (WATs) hold great potential as a low-cost self-monitor-
ing tool to increase PA. Lyons et al [17] reviewed 13 different WATs and their associated apps,
and concluded that they use many behavior change techniques employed in typical PA inter-
ventions (i.e. self-monitoring, feedback, goal-setting). WATs are perceived as useful and
acceptable to individuals with chronic conditions [18]. Thus, WATs may represent a relatively
low-cost, feasible and scalable approach for widespread PA promotion in cancer survivors.
To date, only a few studies have examined the acceptability and usefulness of WATs to pro-
mote physical activity amongst older adults or those with chronic diseases, [18–21] and only
one study has explored acceptability in breast cancer survivors [22]. This found participants
mostly increased their awareness of the amount of time spent active or number of steps
achieved. However, the study recruited only metropolitan breast cancer survivors, and half
were already active.
Little is known about the feasibility of using WATs in interventions with survivors, and in
particular, to promote PA to regional and remote survivors. In order to design and develop
effective interventions, it is essential to first understand the utility of, and preference for
WATs, and WAT features amongst such survivors. The aim of this study is to explore the
acceptability and utility of, and preference for WATs in cancer survivors living in regional and
remote areas of Western Australia, in order to develop more effective interventions.
Methods
Participant recruitment
Following hospital HREC approval (St John of God Healthcare # 1157) participants were iden-
tified from the databases of breast and gynaecologic oncologists in Perth, Australia and from a
list of patients who expressed their interest in future research from previous studies (colorectal
and endometrial). Patients were eligible to participate if they: (i) had completed active treat-
ment for cancer within the preceding five years and deemed to be in remission; (ii) were insuf-
ficiently physically active (i.e., not meeting the recommended 150-minutes of moderate-
intensity PA per week [10]; (iii) resided in a regional and remote areas of WA [23] (i.e., with a
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postcode of 6200+); and, (iv) had daily access to a handheld device or personal computer and
internet. Exclusion criteria were: (i) age<25 and>90 years; (ii) already sufficiently physically
active; (iii) currently using a wearable tracker; (iv) inability to comprehend English.
Patients meeting the inclusion criteria (N = 77) were invited to participate by their treating
oncologist via mail. Patients registered their interest in participating in the study via email or
telephone, and subsequently received a telephone call from a research assistant (RA) to arrange
a convenient time to conduct a telephone screening questionnaire to determine PA status and
eligibility using the Active Australia questionnaire [24]. Participants provided written consent
and gave permission for the interviews to be audio-recorded. They were informed that pseudo-
nyms would be used in reporting of data.
Procedure
The procedure was based on a previous study by co-authors [22] and involved using five com-
mercially available WATs to assess acceptability and feasibility of wearable technology to
increase PA. The selected devices were chosen on the basis that they: (i) included a step-count
function; (ii) included a non-movement notification; (iii) had an associated app; and, (iv) were
affordable (less than $300AUD). Based on these criteria, five devices were selected for testing:
Fitbit Alta, Garmin Vivofit2, Garmin Vivosmart, Polar Loop2 and Polar A300. The selected
devices had a range of different features. For example, the Garmin Vivofit 2 used a long life
battery rather than needing to be charged; the Garmin Vivosmart measured stairs climbed and
the Fitbit had a fixed goal of 10,000 steps.
Participants were assigned two of the five WATs to wear for a minimum of four weeks, two
weeks per device. A one-week non-wear ‘wash out’ period took place between trackers. Some
participants wore a third device, if time permitted and they were interested in trialling a third
device. The expectation was that two wearable trackers would be trialled. A RA mailed written
instructions, alongside the tracker concerning how to initialise their tracker and install the app
on their smartphone. Participants were also given brief information on how to operate the
tracker, its basic features and its app. Tracker features are found in Table 1.
Table 1. Specific features of wearable activity trackers selected for testing in the study.
Specific features Fitbit Alta Garmin Vivofit 2 Garmin Vivosmart Polar Loop 2 Polar A300
Non-movement notification Visual/vibration visual/ audio visual/ vibration Sound/vibration Sound/vibration
Display steps ✓ ✓ ✓ ✓ ✓
Display proportion of steps taken and target goal ✓ ✓ ✓ ✓ ✓
Default or auto goala Default Auto Auto Auto Default
Altimeter (stairs) ✓
Heart Rate ✓
Water resistant (up to 30 metres) ✓ ✓ ✓ ✓
Sleep monitor ✓ ✓ ✓ ✓ ✓
Display Size (mm) 25.5 x 10 25.5 x 10.0 25.3 x 10.7 5 x 17 27.5 x 27.5
Cost (AUD) 150 80 189 119 149
Battery life 7 days 1 year 7 days 21 days 4 weeks
Number of participants testing the device 12 7 8 6 5
a Default or auto-goal: “Default” indicates that devices have default step goals of 10,000 steps per day.
“Auto goal” indicates that devices will create a daily step goal automatically based on user’s previous activity levels, i.e., if user achieved only 5000 steps under the goal of
7,500 steps, the step goal will reduce to 6,500 steps on the next day to make the goal more achievable.
https://doi.org/10.1371/journal.pone.0210039.t001
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Data collection. Semi-structured interviews lasting up to 60-minutes were conducted.
Interviews took place either at the participant’s home, cafe, or via telephone. S1 Fig provides
an overview of the interview guide used with questions concerning experiences, acceptability
and preferences of WATs. Questions also explored the utility of devices to increase PA and/or
reduce sedentary behaviour (SB) and comfort with technology. Interviews were digitally
recorded and transcribed verbatim. Data collection ceased at the point when no new informa-
tion was gained and data saturation was reached [25]. The study adhered to the consolidated
criteria for the reporting of qualitative research (COREQ) [26].
Data analysis
Data were analyzed using thematic analysis [27]. Thematic analysis involved several steps. The
first step involved immersion and involved carefully reading transcripts several times to iden-
tify participants’ meanings. The second step involved attaching codes to salient text segments.
The third step involved the identification of themes at a broader level and examining whether
codes may be combined to form an overarching theme. The final step involved reviewing
themes, cross-checking for overlap and differences and finally defining and classifying themes.
To broaden data interpretation, a second researcher read and coded all transcripts and met
with the first researcher to agree on coding and finalise themes. The analysis offered is one
interpretation of the interviewees’ experiences and we acknowledge that other interpretations
are possible. Nevertheless, we aim to offer a credible and trustworthy interpretation that cap-
tures participants’ perceptions and experiences. For example, we provide ‘thick description’
via the use of extensive and direct quotations so that the reader can evaluate the interpretation
[28].
Results
Seventy-seven cancer survivors were invited to participate. Of these seven (9%) expressed
interest but were ineligible. Twenty survivors participated in the trial (26%). Sixteen (14 female
and 2 male) completed the study with a mean age of 63 (SD 13) years. There were no signifi-
cant differences in age (t (73) = 1.29, p = 0.20) and months since diagnosis (t (73) = -0.43,
p = 0.67) of participants that completed the study compared to those who declined participa-
tion or dropped out. Participant demographics and study tracker allocation are summarized in
Table 2 and Table 3 respectively.
Analysis of the data identified four main themes: Increasing Self-Awareness of PA and SB;
Prompts and Feedback; Accuracy and registry of activities; WAT preferences and features. Sev-
eral participants purchased (n = 5) their own WAT following participation in the study and
several others (n = 8) were considering purchasing one. Pseudonyms are used throughout the
manuscript. A summary of the themes and illustrative quotes can be found in Table 4.
Increasing self-awareness of PA and SB
Most participants reported that the trackers made them more conscious of their PA and SB:
“they motivated me. . .made me very aware of how much I’m moving and that I need to move
more” (Lisa, aged 49). Self-awareness of PA was viewed as important and the WATs provided
this awareness: “I think it helps to know how much you’re doing, what you’re doing” (Emma,
aged 50) and “It certainly prompts my mind to think you’re not doing enough” (Sandra, aged
68). Several participants expressed surprised at the effort needed to reach the recommended
steps: “If you’re doing something very stationery I was surprised that you didn’t get much of a
count” (Paul, aged 52) and “makes you more aware because I have an office job . . .you don’t
take as many steps during those days” (Anna, aged 35). Awareness of SB was also identified:
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“just look at how much time you spent sitting” (Diane, aged 67) and “I’ve got to move because
this thing’s telling me I’ve been sitting too long” (Elsa, aged 78). In recognition of negative
cases, only one participant did not enjoy using the WATs: “I was always worried about steps,
steps, steps. . .you’ve got to do steps. It’s intrusive on my life” (Miriam, aged 67).
Prompts and feedback
The provision of prompts and feedback were the most motivational aspects of the WATs. The
WATs acted as a prompt: “yeah it prompted me to go. . .like I could have gone up the escalator
but I elected to go up the stairs. . .and then I was cross because it didn’t show (record stairs
climbed)” (Carol, aged 68) and for Paul “it prompted me to do it. . .I knew that if I went for a
decent walk then I’d always get the 10000” (Paul, aged 52). Real time feedback was important
to nudge behaviour and meet goals: “Geez I haven’t done enough sometimes at night I’m 500
short so I go outside in the dark and check on the animals to get my 10000” (Karen, aged 51).
Participants also found the automated prompts to move motivating: “every time it buzzed,
you got up and moved so you feel great success” (Diane, aged 67) and “last night I looked—
ahh that’s the red mark!, so I jumped off the chair and round I went. . .if I didn’t have that on I
wouldn’t keep doing it” (Elsa, aged 79). However, several participants found these reminders
too simplistic and in the case of the Garmin’s ‘MOVE!’ prompt, rude: “It buzzed at you and
went MOVE . . . even had an exclamation mark, it’s like ‘seriously’ you get slightly offended”
Table 2. Participant characteristics.
Age (years)
Mean 62.58
SD 12.92
Range 35–78
Marital Status
Married/living together 13
Separated 2
Not married 1
Highest completed education
Primary 1
Secondary/high school 1
Post-school vocational 6
University
Not reported
4
4
Annual household income
<AUS$ 20,000 1
AUS$ 20,001–$ 39,999 2
AUS$ 40,000–$ 59,999 4
AUS$ 60,000–$ 79,999 1
AUS$ 80,000 + 3
Not reported 5
Employment
Full-time 6
Part-time 3
Retired 6
Homemaker 1
https://doi.org/10.1371/journal.pone.0210039.t002
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(Emma, aged 50). For Paul, these prompts were rather ‘Pavlovian’; he offered his thoughts on
what may work:
“Quantitative data are good because you’re reminded that you’re not meeting your targets. . .if
set at 10,000 and you get 7,000 for a couple of days then maybe you could get direct mes-
sages, bit of a psych talk. . .automated but make it personalised, you missed your target for a
few days rather than saying Move!”
Several participants also referred to the feedback and praise concerning achievements as
important and motivational: “very motivational feedback. . .computer graphics, gave you your
percentage ranking for the day so you could see how you were getting better” (Diane, aged 67,
referring to Polar A300) and “all of them had a goal for the day. . .the step goal was good. . .it
said you’d done over 200% of your step goal” (Maureen, aged 65).
Accuracy and registry of activities
The accuracy of statistics was identified as a theme and related predominantly to the accuracy
of the Fitbit which had a tendency to count arm movements as steps: “Watch this (shakes arm)
I said what’s the number and I went like this (shakes arm) and she went oh. . .it can be tricked”
(Maureen, aged 65) and “I’m not sure I believe them, it’s quite easy to get the steps in. . ..wash-
ing dishes or sanding something down, I tended to get the 10,000 steps pretty easy” (John,
aged 69). The Polar A300 also misreported activity: “My hand was moving for a couple of min-
utes, it thought I was running” (Diane, aged 67).
The inaccuracy of the Fitbit led to a false sense of achievement for some. For example,
Linda found that it was relatively easy to accumulate steps: “I cleaned the house on Saturday
and I did 9,800 steps just cleaning. . .it doesn’t take much at all (Linda, aged 51). For others,
there was disappointment because the WATs didn’t record other activities such as swimming:
“it doesn’t take into account other exercise like swimming” (Miriam, aged 67), cycling: “I
found (cycling) a bit tricky to track so I put in the kilometers in an area of the App” (Lisa, aged
49) or gardening: “It doesn’t record gardening at all” (Maureen, aged 65).
Table 3. Overview of participants and wearable activity trackers trialed.
Participant Age Cancer Type Treatment 1st tracker 2nd tracker 3rd tracker
1 50–59 Uterine SU+CH+RA Garmin Vivofit 2 Polar Loop 2 Garmin VivoSmart
2 50–59 Colorectal SU+CH Garmin VivoSmart Polar A300 Fitbit Alta
3 60–69 Colorectal SU+CH Garmin VivoSmart Polar Loop 2 N/A
4 60–69 Breast SU+CH+RA Garmin VivoFit 2 Polar Loop 2 Garmin VivoSmart
5 60–69 Colorectal SU Garmin VivoSmart Fitbit Alta Polar A300
6 50–59 Ovarian SU+CH Fitbit Alta Garmin VivoFit 2 N/A
7 40–49 Breast SU+CH+RA Fitbit Alta Garmin VivoSmart N/A
8 60–69 Breast SU+CH Garmin VivoFit 2 Fitbit Alta Polar Loop 2
9 70–79 Breast SU+CH+RA Garmin VivoSmart Polar A300 N/A
10 50–59 Breast SU+CH+RA Fitbit Alta Polar Loop 2 N/A
11 70–79 Breast SU+RA+HR Polar Loop 2 Fitbit Alta Garmin VivoFit 2
12 60–69 Colorectal SU Fitbit Alta Polar A300 N/A
13 30–39 Breast SU+CH Fitbit Alta Polar Loop 2 Garmin VivoFit 2
14 50–59 Breast SU+CH Fitbit Alta Garmin VivoFit 2 N/A
15 50–59 Endometrial SU+CH+RA Fitbit Alta Polar A300 N/A
16 60–69 Endometrial SU+RA Garmin VivoSmart Fitbit Alta N/A
Note. SU = Surgery; CH = Chemotherapy; RA = Radiotherapy; HR = Hormone Therapy
https://doi.org/10.1371/journal.pone.0210039.t003
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WAT preferences and features
WAT preferences and features contain two sub-themes: appearance and functionality, and
preferred features.
Appearance and functionality. Appearance was a commonly cited factor in relation to
acceptability. The most aesthetically pleasing WAT was the Fitbit because of its slim band and
small face: “I thought that one was quite sleek. . . not overbearing or overstated” (Paul, aged
52) and “from an aesthetic point of view it’s more stylish” (Fiona, aged 50). Participants also
liked the appearance of the Garmin VivoSmart (“I like this watch. . .the face stays on” (Lisa,
Table 4. Overview of themes and illustrative quotes.
Theme Brief description Illustrative quotes
Increasing self-awareness
of PA and SB
WATs increased participant self-awareness of their SB and PA. “It made me get out. . .take the dog for a walk. . .walk around the yard
(to) get my steps up” (P6, aged 50–59)
“Knowledge is power, so it’s the reality of it that you might think
you’re doing a certain amount of activity but having it written down
helps” (P1, aged 50–59)
“The main benefit was it tells you how many steps you’ve done so it’s
like quantifying how much exercise that we’re getting on a daily
basis” (P2, aged 50–59)
“I get home and I’ve only done 3000 steps for the whole day which
obviously isn’t enough so it makes you more conscious to keep
moving and try move a bit more” (P10, aged 50–59)
Prompts and Feedback The most motivational dimensions of the WATs was the provision
of prompts and feedback.
“The beep makes you look at the watch and then it tells you it’s time
to move. . .I thought ok I’ll go get a drink of water or something” (P5,
aged 60–69)
“If I’m watching telly and the ads come on I get up off the chair
around the lounge, down the passage through the kitchen to increase
my steps, if I didn’t have that on I wouldn’t keep doing it” (P11, aged
70–79)
“It prompted me to go for a bit extra walking” (P16, aged 60–69)
“Fitbit sends you a weekly report. . .fireworks on the screen when you
reached your target” (P15, aged 50–59)
Accuracy and Registry of
Activities
The accuracy of statistics (primarily step count) was questioned by
several participants, mainly with reference to the Fitbit which had a
tendency to over count steps during sedentary or light activity.
Others expressed disappointment because the WATs did not
record other activities such as stair climbing, swimming, gardening
or cycling.
“The Fitbit needs to be made more accurate, it’s giving people a false
sense of achievement” (P14, aged 50–59)
“I did an hour of yoga but it didn’t register that” (P8, aged 60–69)
“The first one was really nice except, that I climbed up all these stairs
deliberately because I wanted it recorded. And I did four flights of,
five flights of stairs and it recorded one (Garmin Vivosmart) (P3,
aged 60–69)
“Digging up a hole, large tree stump shurbs. . .didn’t record as an
activity. . .you might get a little disillusioned, what have I got to do to
get an activity recorded” (P4, aged 60–69)
WAT Preferences:
Appearance &
Functionality
Appearance and functionality were commonly cited in relation to
acceptability and usability. Most participants preferred WATS with
a slim band.
“The Fitbit is quite difficult to put on” (Miriam, aged 67); “I much
preferred the Fitbit because it was smaller and easier to work with”
(P12, aged 60–69).
“This one (Fitbit) was smaller, less bulky and easier to see” (P10, aged
50–59)
“This is a cute little one (Garmin Vivofit), it fits my wrist
perfectly. . .you don’t even have to charge it” (P11, aged 70–79)
WAT Preferences and
Features: Preferred
Features
The most popular feature was step counting. Several wanted the
WAT to have a heart rate monitor. WATs that were easy to sync
were also viewed favourably.
“All I ever focused on was the step count” (P5, aged 60–69); “I used
them for steps mainly” (P15, aged 50–59)
“But I like the heart rate monitor on that one [Garmin] which I
thought was good” (P2, aged 50–59); “The syncing was a pain on that
one (Garmin Vivosmart) but the tapping (Fitbit) was also a pain” (P6,
aged 50–59)
“With the Garmin, I didn’t get on that well with it, couldn’t work out
a lot of things to do with it, with the Fitbit I was able to download the
app and follow it a bit more. . .it records the calories and steps” (P16,
aged 60–67)
https://doi.org/10.1371/journal.pone.0210039.t004
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aged 49) and VivoFit, as they were both slim in appearance. The Polar Loop was also popular
in appearance but perceived as uncomfortable since it’s more like a bangle and would slide
around. The Polar A300 was not visually appealing and often described as bulky and clunky:
“The polar was too big on, too clunky so I took it off” (John, aged 69).
The most common complaint regarding useability concerned the Fitbit. Participants often
spoke about experiencing difficulties putting the band on: “I physically could not press those
metal things through so I had to have my husband put it on” (Carol, aged 68) and problems
looking at the statistics: “I kept tapping and tapping and nothing would happen” (Miriam,
aged 67) and “you had to find x marks the spot” (Elsa, aged 78). The Garmin VivoFit was
described with differing opinions. Some participants liked the security of the clip to lock in the
band, whilst others found it awkward and annoying: “that was far too hard to do it your-
self. . .that was one that was two little hooks in” (Maureen, aged 65). The Garmin Vivosmart
was popular because it had a normal watch strap: “I’m seriously thinking of getting a Garmin
(vivosmart). . .I like the fact it had a proper strap” (Carol, aged 68), and displayed clear text:
“For an older person, I would give them the Garmin because of its bigger writing and more
accurate” (Karen, aged 51).
There were few issues reported concerning limited tech-knowledge even amongst the older
participants: “pretty straight forward. . .for a techo nerd” (Carol, aged 68) and “I’ve got the
piece of paper sat down, got my phone out, had to press the button, hang onto it until the
word came up, perfect” (Elsa, aged 78). Only one participant did not understand how to use
them: “I’m not very computer literate. . .I couldn’t get it to work” (Sue, aged 78). All partici-
pants engaged with the Apps apart from Elsa and Sue. Elsa was content using solely the device
to self-monitor her activity and Sue was unable to set up either device.
Preferred features. The most popular feature across all WATs was the step counting
which promoted self-awareness. Most participants’ desired simple features as summarised
by Elsa “What time it is, how many steps I’ve done, how far I’ve gone, that’s all I wanted”
(aged 78). Most participants found the automated prompts to increase step count as motiva-
tional, however the tone of the prompt was important. The tone of the Garmin was perceived
as abrupt and rude whereas the tone of the Fitbit was experienced as more polite: “I’d get a lit-
tle vibration to say let’s go do 250 steps, it was much more polite than MOVE” (Fiona, aged
50).
Trackers that were easy to sync (i.e., Fitbit) were also viewed favorably. There was also a
preference for the Fitbit app: “Fitbit was superior for quick syncing and notifications associ-
ated with the App. . .had a lot more versatility. . .it was on autosync. . .the Garmin you had to
force sync” (Fiona, aged 50), and, “Garmin was a bit more complex to set up. . .even with the
food/ drinking you had to get a different app called Myfitnesspal” (Lisa, aged 49).
The less preferred features have been highlighted and include issues relating to the accuracy
of trackers and disappointment that WATs did not effectively capture all activities. For some,
the auto-goal function on some trackers caused confusion: “it wasn’t clear like now the goal,
does that mean I have to do 5000 steps, why have they got that I’ve been doing over 10000”
(Elsa, aged 78). Despite the study recruiting regional and remote survivors, there were very
few concerns regarding internet availability. Only Anna mentioned this: “The internet and
phone coverage is bad. . .that is a barrier if you want to download apps. . .sometimes you have
to use mobile data to look at your statistics”.
Discussion
This is the first study to explore the experiences, acceptability and usability of WATs amongst
rural cancer survivors. Despite the evidence of the importance of PA for healthy survivorship
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[4–9], few survivors meet the PA guidelines [10]. As a powerful self-monitoring tool, WATs
present a potential opportunity for PA promotion and in particular, to reach survivors living
in rural communities. WATs may also play a role in objectively monitoring patient PA
remotely and used to predict important clinical outcomes such as readmission. A recent study
found that a higher mean daily step count, derived from the Fitbit, predicted lower risk of
readmission following metastatic peritoneal cancer [29]. In addition to the use of WATs to
promote PA to survivors following active treatment to prevent CVD, WATs could also play an
important role in identifying opportunities for real-time adaptive interventions during cancer
treatment to improve clinical outcome [29, 30].
We found that WATs increased self-awareness of their PA and SB consistent with previous
research [18,20]. The provision of prompts and feedback were the most motivational aspects
of the WATs. The trackers provided continuous self-monitoring and real time feedback in
relation to step goals and appeared to reinforce progress or nudge behaviour towards goals.
Recognition of achievements (either from the device or through the App) were also enjoyed by
participants. The motivational nature from immediate feedback on step count and progress
towards step goals has been reported previously [20]. The features of WATs that most moti-
vated participants (i.e., monitoring behavior, prompts, setting goals, receiving feedback) are
also behavior change techniques known to be effective for promoting PA [31,32]. For example,
‘provide instruction’ and ‘reinforcing efforts towards behavior’ are techniques associated with
a significant increase in PA [32]. Interventions that employ self-monitoring and at least one
other self-regulatory technique (i.e., goal setting, receiving feedback on performance, review of
goals) are significantly more effective in promoting PA [31].
The majority of participants found the WATs to be highly acceptable and useful consistent
with previous research in older populations, [19,21] chronic disease [18,20] and breast cancer
survivors [22]. This is the first study to indicate that the provision of written instructions and/
or telephone technical support in conjunction with WATs may be sufficient in rural survivors
and that such interventions do not require face-to-face contact. Only one participant reported
finding the devices intrusive and one other who was unable to use the technology.
Some were sceptical of the authenticity of the Fitbit-recorded data, noting that it tended to
over-count steps. Others failed to notice the devices misclassifying steps during SB or light
activity leading to a false sense of achievement. However, research supports the accuracy of
WATs, including the Fitbit for counting steps [33,34]. The reliability and validity of two Fitbit
models (Flex and ChargeHR) has shown to be good in older adults (aged over 65), with high
intra class correlations of the WATs with direct observation of steps [35]. Good strength of
agreement was also found for total distance and moderate-to-vigorous physical activity in the
free-living environment compared to an accelerometer [35]. A further study in older adults
also found excellent agreement between the Fitbit (One and Zip) and direct observation for
step count, and also between the Fitbit and Actigraph for average step count/per day over
7days [36]. It would appear that Fitbit trackers are sufficiently accurate to be used in commu-
nity-dwelling older adults to increase physical activity. The over-count of steps found in the
present study appears to occur only during light household activities. Therefore, future trials
should ensure the device is worn on the non-dominant wrist or taken off when performing sta-
tionery activities involving much arm movement. Some participants were disappointed that
activities such as swimming and cycling were not recorded by the device. Such frustration that
WATs fail to register activities has been noted elsewhere [20]. This is a limitation with some
models which are not waterproof and/or do not have more sophisticated features.
In relation to preferences, the aesthetics of the WATs were deemed crucial in determining
preference and likelihood of use, consistent with previous research [18, 21,22]. The smaller
trackers were mostly preferred with the Fitbit Alta being considered the most stylish. The
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Garmin models were also favourable due to their slim in appearance and because the screen
was bigger and the display stayed on. The most common complaint regarding useability con-
cerned the Fitbit Alta and difficulties tapping to view the statistics. The acceptability of WATs
is highly influenced by device characteristics such as display, comfort and most of all
aesthetics.
The most preferred feature across WATs was step counting and this is consistent with the
previous study in breast cancer survivors [22]. The prompts were deemed helpful although the
tone of the prompt was considered important. The Fitbit appeared to be the preferred App;
participants found it more intuitive and some were interested in self-monitoring food intake,
which were not available on other Apps.
Clinical implications
The WATs provided self-monitoring and real time feedback in relation to step goals and rein-
forced progress and efforts towards goals. Future interventions may do well to have two differ-
ent WATs available for participants to choose from, according to activity preferences, aesthetic
preferences, and display size.
Strengths and limitations
Our study has certain limitations including a low response rate, which may have introduced
response bias. Additionally, our sample is predominantly female (87.5%) (since patient enrol-
ment was limited to databases with a heavy preponderance of female malignancies including
breast and gynecologic). Therefore we cannot assume that our findings are transferable to
male cancer survivors, particularly the findings in relation to aesthetic preferences. Further,
extended-term acceptance could not be explored. A study strength is the recruitment of under-
served survivors living in rural areas, and the first feasibility testing of providing WATs with
written instructions and/or telephone technical support.
Conclusion
WATs appear to be acceptable to cancer survivors living in rural locations and may represent
a low-cost, feasible and scalable approach for PA promotion. WATs increased self-awareness
of physical activity, provided real time feedback in relation to goals, and reinforced progress
and efforts toward goals. The aesthetics of the WATs were deemed crucial in determining like-
lihood of use. Future interventions may do well to have two different WATs available for par-
ticipants to select from, according to activity preferences, aesthetic preferences and display
size. Future research should explore whether WAT use and increased PA is sustained over
time.
Supporting information
S1 Fig. Interview guide. The interview guide provides examples of questions used during
interviews concerning experiences, acceptability and preferences of WATs.
(PDF)
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